Cue Biopharma, Inc. Short-term Debt
Cue Biopharma, Inc. (CUE) had Short-term Debt of $100.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Short-Term Debt
us-gaap:ShortTermBorrowings · last filed 2025-05-12
- 2025-03-31: Short-term Debt $100.00K.
- 2024-12-31: Short-term Debt $37.00K.
- 2024-03-31: Short-term Debt $37.00K.
- 2023-12-31: Short-term Debt $37.00K.
| Period end | Short-term Debt |
|---|---|
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $37.00K 10-K · filed 2025-03-31 |
| 2024-03-31 | $37.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $37.00K 10-K · filed 2024-03-28 |
| 2022-12-31 | $73.97K 10-K · filed 2023-03-21 |
| 2022-09-30 | $37.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |